Wikidata

(Q42598004)

English

A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.

scientific article published on April 2003

In more languages

Statements

title
A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12717239
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12717239%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42598004&oldid=2109768293"